Skip to main content
logo
BCAL Diagnostics Limited (ASX:BDX)
Australia flag Australia · Delayed Price · Currency is AUD
0.0860
+0.0160 (22.86%)
Sep 17, 2026, 3:34 PM AEST

BCAL Diagnostics Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
2.352.352.653.052.790.72
Revenue Growth
-7.31%-11.25%-13.01%9.18%288.29%161.09%
Gross Profit
2.352.352.653.052.790.72
Operating Income
-7.07-7.07-7.12-6.08-4.79-3.05
Net Income
-7.37-7.37-7.24-6.4-5.06-3.39
Earnings Per Share
-0.02-0.02-0.02-0.03-0.02-0.02
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
1.591.594.526.473.179.57
Total Debt
6.926.922.381.521.06-
Net Cash (Debt)
-5.33-5.332.144.952.119.57
Net Cash Growth
---56.68%134.25%-77.93%180.88%
Net Cash Per Share
-0.01-0.010.010.020.010.05

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-6.16-6.16-6.14-4.52-6.05-3.22
Capital Expenditures
-0.46-0.46-0.79-1.15-0.36-0.03
Free Cash Flow
-6.62-6.62-6.92-5.67-6.41-3.25
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-300.54%-300.54%-268.73%-199.51%-171.55%-424.13%
Pretax Margin
-313.39%-313.39%-273.21%-210.07%-181.39%-471.08%
Profit Margin
-313.38%-313.38%-273.21%-210.07%-181.39%-471.08%
FCF Margin
-281.40%-281.40%-261.23%-186.23%-229.72%-451.54%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
10.9711.768.7012.905.3323.09